4//SEC Filing
Susi Roger E. 4
Accession 0001613801-26-000006
CIK 0001325618other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:05 PM ET
Size
11.1 KB
Accession
0001613801-26-000006
Research Summary
AI-generated summary of this filing
IRADIMED (IRMD) 10% Owner Roger Susi Sells Shares
What Happened
Roger E. Susi, listed as a 10% owner of IRADIMED Corp (IRMD), sold a total of 5,000 shares in open-market transactions on January 20, 2026, for aggregate proceeds of approximately $509,225. The sales were reported as three disposals: 2,129 shares at a weighted average price of $101.03 (≈ $215,093), 1,074 shares at $102.03 (≈ $109,580), and 1,797 shares at $102.70 (≈ $184,552). These were sales (S) — routine dispositions rather than purchases or option exercises.
Key Details
- Transaction date: January 20, 2026; Form 4 filed January 21, 2026 (appears timely under Section 16 reporting requirements).
- Individual trade details:
- 2,129 shares @ $101.03, proceeds ≈ $215,093 (weighted avg; underlying prices $100.50–$101.48).
- 1,074 shares @ $102.03, proceeds ≈ $109,580 (weighted avg; underlying prices $101.56–$102.48).
- 1,797 shares @ $102.70, proceeds ≈ $184,552 (weighted avg; underlying prices $102.62–$102.86).
- Total: 5,000 shares sold for ≈ $509,225.
- Sales were made pursuant to a Rule 10b5-1 trading plan adopted June 16, 2025 (Footnote F1).
- Reporting person disclaims beneficial ownership except to extent of pecuniary interest (Footnote F5).
- Shares owned after the transactions: not disclosed in the information provided in this summary.
Context
- A Rule 10b5-1 plan allows insiders to pre-arrange trades; such sales often reflect pre-set plans or portfolio management rather than a contemporaneous view on the company.
- Because this is a sale by a 10% owner (a significant shareholder), retail investors should note the size of the holder but avoid assuming the sale signals company fundamentals without additional information.
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
Susi Roger E.
DirectorCEO, PRESIDENT, CHAIRMAN10% Owner
Transactions
- Sale
Common Stock
[F1][F2]2026-01-20$101.03/sh−2,129$215,093→ 2,270,371 total(indirect: By Trust) - Sale
Common Stock
[F1][F3]2026-01-20$102.03/sh−1,074$109,580→ 2,269,297 total(indirect: By Trust) - Sale
Common Stock
[F1][F4]2026-01-20$102.70/sh−1,797$184,552→ 2,267,500 total(indirect: By Trust)
Holdings
- 162,950(indirect: By Trust)
Common Stock
- 2,062,500(indirect: By Trust)
Common Stock
[F5]
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $100.50 to $101.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $101.56 to $102.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $102.62 to $102.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Roger E. Susi|2026-01-21
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001613801
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:05 PM ET
- Size
- 11.1 KB